332393-17-6(4-(4-methoxyphenyl)-1-[(2-methyl-2-propenyl)sulfanyl]-6,7,8,9-tetrahydro[1]benzothieno[3,2-e][1,2,4]triazolo[4,3-a]pyrimidin-5(4H)-one)
Product Description
332393-17-6
CAS No.
332393-17-6
Chemical Name:
4-(4-methoxyphenyl)-1-[(2-methyl-2-propenyl)sulfanyl]-6,7,8,9-tetrahydro[1]benzothieno[3,2-e][1,2,4]triazolo[4,3-a]pyrimidin-5(4H)-one
CBNumber:
CB82030717
Molecular Formula:
C22H22N4O2S2
Formula Weight:
438.57
MOL File:
Mol file
4-(4-methoxyphenyl)-1-[(2-methyl-2-propenyl)sulfanyl]-6,7,8,9-tetrahydro[1]benzothieno[3,2-e][1,2,4]triazolo[4,3-a]pyrimidin-5(4H)-one Synonyms:
4-(4-methoxyphenyl)-1-[(2-methyl-2-propenyl)sulfanyl]-6,7,8,9-tetrahydro[1]benzothieno[3,2-e][1,2,4]triazolo[4,3-a]pyrimidin-5(4H)-one
[1]Benzothieno[3,2-e][1,2,4]triazolo[4,3-a]pyrimidin-5(4H)-one, 6,7,8,9-tetrahydro-4-(4-methoxyphenyl)-1-[(2-methyl-2-propen-1-yl)thio]-
4-(4-methoxyphenyl)-1-[(2-methyl-2-propenyl)sulfanyl]-6,7,8,9-tetrahydro[1]benzothieno[3,2-e][1,2,4]triazolo[4,3-a]pyrimidin-5(4H)-one
Property
Boiling point:
717.8±70.0 °C(Predicted)
Density
1.43±0.1 g/cm3(Predicted)
pka
0.89±0.20(Predicted)
Safety
4-(4-methoxyphenyl)-1-[(2-methyl-2-propenyl)sulfanyl]-6,7,8,9-tetrahydro[1]benzothieno[3,2-e][1,2,4]triazolo[4,3-a]pyrimidin-5(4H)-one
Suppliers
Global( 3)Suppliers
Finland 2
The Netherlands 1
Global 3
Supplier
Tel
Email
Country
ProdList
Advantage
PHARMEKS Ltd.
+7 (495) 702-9648
sales@pharmeks.com
Finland
6349
50
Interbioscreen Ltd.
+7 (49) 6524-0091
screen@ibscreen.chg.ru
Finland
6176
60
Specs
+31 15 251 8111
info@specs.net
The Netherlands
6833
70
332393-17-6(4-(4-methoxyphenyl)-1-[(2-methyl-2-propenyl)sulfanyl]-6,7,8,9-tetrahydro[1]benzothieno[3,2-e][1,2,4]triazolo[4,3-a]pyrimidin-5(4H)-one)
Related Search:
4-(4-methoxyphenyl)-1-[(2-methyl-2-propenyl)sulfanyl]-6,7,8,9-tetrahydro[1]benzothieno[3,2-e][1,2,4]triazolo[4,3-a]pyrimidin-5(4H)-one
[1]Benzothieno[3,2-e][1,2,4]triazolo[4,3-a]pyrimidin-5(4H)-one, 6,7,8,9-tetrahydro-4-(4-methoxyphenyl)-1-[(2-methyl-2-propen-1-yl)thio]-
332393-17-6
Copyright 2017 © ChemicalBook. All rights reserved